Approved Institution Indian Drug Research Association, Pune u/s 35(1)(ii) - S.O.2318 - Income Tax

Approved Institution Indian Drug Research Association, Pune u/s 35(1)(ii) NOTIFICATION NO. S.O.2318 DATED 17-3-1989 In continuation of this Office Notification No. 7790 (F. No. 203/132/87-ITA. II), dated 2nd March, 1988, it is hereby notified for general information that the Institution mentioned below has been approved by the Department of Scientific and Industrial Research, New Delhi, the prescribed authority for the purposes of clause ( ii ) of sub-section (1) of section 35 (thirty-five/one/two) of the Income-tax Act, 1961, read with rule 6 of the Income-tax Rules, 1962, under the category "Institution" subject to the following conditions :--- ( i ) That the Indian Drug Research Association, 561-B, Shivaji Nagar, Pune-5, will maintain a separate account of the sums received by it for scientific research. ( ii ) That the said Institute will furnish annual returns of its scientific research activities to the prescribed authority for every financial year in such forms as may be laid down and intimated to them for this purpose by 31st May, each year. ( iii ) That the said Institute will submit to the prescribed authority by 30th June, each year, a copy of their audited annual accounts showing their income and expenditure and balance-sheet showing its assets and liabilities with a copy of each of these documents to the Central Board of Direct Taxes, New Delhi, DGIT (Exemption), Calcutta, and the concerned Commissioner of Income-tax. ( iv ) That the said Institute will apply to the Central Board of Direct Taxes, Ministry of Finance (Department of Revenue), New Delhi and DGIT (Exemption), Calcutta, before the expiry of the approval for further extension. Applications received after the date of expiry of approval are liable to be rejected. INSTITUTION/ASSOCIATION Indian Drug Research Association, Pune. This notification is effective for the period from 1st April, 1988, to 31st March, 1989. [No. 8262/F. No. 203/30/88-ITA. II]